August 20, 2026

News, minutes after it breaks

Technology
Latest
Giants Defensive Line Dominates Dolphins as Fighting Disrupts Joint PracticeUK Prime Minister Announces National Crime Agency Crackdown on Illegal Waste GangsGCSE Pass Rates Dip Slightly Across UK Nations as Retake Policy Faces ScrutinyMelting Sea Ice Draws Thousands of Giant Whales to East GreenlandTrump Threatens Severe Penalties for Countries Doing Business With IranRussian Air Strikes Kill at Least 15 in Kyiv Amid Missile Defense ShortagesPatriots Receiver A.J. Brown Reunites With Former Eagles Teammates at Joint PracticeTogo charges two French journalists over incorrect documents, rights group saysGiants Defensive Line Dominates Dolphins as Fighting Disrupts Joint PracticeUK Prime Minister Announces National Crime Agency Crackdown on Illegal Waste GangsGCSE Pass Rates Dip Slightly Across UK Nations as Retake Policy Faces ScrutinyMelting Sea Ice Draws Thousands of Giant Whales to East GreenlandTrump Threatens Severe Penalties for Countries Doing Business With IranRussian Air Strikes Kill at Least 15 in Kyiv Amid Missile Defense ShortagesPatriots Receiver A.J. Brown Reunites With Former Eagles Teammates at Joint PracticeTogo charges two French journalists over incorrect documents, rights group says

Home  / Technology

mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say

Technology Ars Technica
Image: Ars Technica

The vaccine reportedly thwarted the cancer's return and spread.

Ars Technica reported this story. Read the full report on arstechnica.com →

This is a short summary. Ars Technica wrote and published the full report.

Continue on arstechnica.com →

More in Technology

Leave a Reply

Your email address will not be published. Required fields are marked *